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Mammals have three HP1 protein isotypes HP1β (CBX1), HP1γ (CBX3) and HP1α (CBX5) that are encoded by the
corresponding genesCbx1, Cbx3 andCbx5. Recent work has shown that reduction of CBX3 protein in homozygotes for a
hypomorphic allele (Cbx3hypo) causes a severe postnatal mortality with around 99% of the homozygotes dying before
weaning. It is not known what the causes of the postnatal mortality are. Here we show that Cbx3hypo/hypo conceptuses are
significantly reduced in size and the placentas exhibit a haplo-insufficiency. Late gestation Cbx3hypo/hypo placentas have
reduced mRNA transcripts for genes involved in growth regulation, amino acid and glucose transport. Blood vessels
within the Cbx3hypo/hypo placental labyrinth are narrower than wild-type. Newborn Cbx3hypo/hypo pups are hypoglycemic,
the livers are depleted of glycogen reserves and there is almost complete loss of stored lipid in brown adipose tissue
(BAT). There is a 10-fold reduction in expression of the BAT-specific Ucp1 gene, whose product is responsible for non-
shivering themogenesis. We suggest that it is the small size of the Cbx3hypo/hypo neonates, a likely consequence of
placental growth and transport defects, combined with a possible inability to thermoregulate that causes the severe
postnatal mortality.
[Aydin E, Kloos D-P, Gay E, Jonker W, Hu L, Bullwinkel J, Brown JP, Manukyan M, Giera M, Singh PB and Fundele R 2015 A hypomorphic Cbx3
allele causes prenatal growth restriction and perinatal energy homeostasis defects. J. Biosci. 40 325338] DOI 10.1007/s12038-015-9520-x
1. Introduction
HP1 proteins are small adapter proteins that are constituents
of larger complexes involved in a variety of nuclear
functions (Canzio et al. 2014). These include roles in het-
erochromatin formation, positive and negative transcription-
al regulation, DNA repair, chromosome segregation and
replication of heterochromatin (reviewed in Grewal and
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Elgin 2007; Billur et al. 2010). In mammals, there are three
HP1 isotypes, HP1β (CBX1), HP1γ (CBX3) and HP1α
(CBX5), that are encoded by distinct genes, chromobox
homolog 1 (Cbx1), Cbx3 and Cbx5, respectively (Jones
et al. 2000). The three HP1 isotypes possess extensive se-
quence similarity, but this similarity belies their non-
redundant functions. The suggestion that the mammalian
HP1 isotypes are likely to possess non-redundant functions
came first from immunolocalization studies using isotype-
specific antibodies. CBX1 and CBX5 proteins were found to
be concentrated at sites of constitutive heterochromatin
(Saunders et al. 1993; Wreggett et al. 1994), while CBX3
was shown to have a more euchromatic distribution (Horsley
et al. 1996). It was suggested that its euchromatic distribu-
tion reflected the acquisition of new functions by CBX3 and
subsequently it was shown that CBX3 is associated with
euchromatic genes and is involved in elongation and pro-
cessing of their mRNA transcripts (Vakoc et al. 2005;
Hediger and Gasser 2006; Smallwood et al. 2012).
Proof that HP1 isotypes were non-redundant came from
mutational analyses. It was demonstrated that loss of CBX1
protein cannot be compensated by CBX3 and CBX5 proteins
(Aucott et al. 2008) because the murine Cbx1−/− mutation is
perinatal lethal. Mortality is caused by respiratory failure due
to defective post-synaptic differentiation in the diaphragm
(Aucott et al. 2008). In addition, while other organ systems
seemed intact, Cbx1−/− mutants exhibited defective develop-
ment of the central nervous system that was associated with a
profound genomic instability (Aucott et al. 2008). Deletion
of the CBX5 protein had no obvious effect. Cbx5−/− mice are
fully viable and fertile (cited in Aucott et al. 2008), indicat-
ing a redundancy, most likely with CBX1. However, a recent
study has shown that Cbx5−/− mice exhibit a specific defect
in the silencing of TH1 expression in TH2 cells (Allan et al.
2012). These data show that CBX protein function(s) are
likely to be overlapping, but there are non-redundant func-
tions peculiar to each isotype that cannot be compensated
and some of these functions may be quite specific in
character.
Ablation of Cbx3 expression causes infertility in both
sexes and a severe neonatal mortality (Brown et al. 2010;
Abe et al. 2011; Takada et al. 2011). In one study, which
used a hypomorphic Cbx3 allele (Cbx3hypo), roughly 99% of
the homozygous mutants died before weaning, whereas on
day 19 of fetal development (E19) normal Mendelian ratios
of wild-type to targeted alleles were observed (Brown et al.
2010). In all Cbx3hypo/hypo tissues examined the levels of
CBX3 protein were barely detectable (Brown et al. 2010).
The causes for the neonatal demise of Cbx3hypo/hypo homo-
zygotes are not known. Here we describe the cellular and
molecular changes that take place inCbx3hypo/hypo conceptuses
and newborns. Our findings indicate that the Cbx3hypo/hypo
mutation is pleiotropic and causes generalized defects in
placental development and energy homeostasis that are
together responsible for the postnatal mortality of
Cbx3hypo/hypo homozygotes.
2. Materials and methods
2.1 Mice and mouse tissues
All experiments with mice were conducted according to the
guidelines issued by Uppsala University. The Cbx3hypo al-
lele, which has been described in detail in Brown et al.
(2010), was propagated as heterozygote in a mixed
C57BL6/129 genetic background at the Borstel Research
Center and subsequently at the animal facilities at the
Biomedical Center, Uppsala, where the allele was crossed
into a BALB/c background to backcross 3. No obvious
differences could be observed between fetuses from matings
with different strain combinations and consequently results
are pooled. Pregnant females were killed by cervical dislo-
cation, with the day of vaginal plug being counted as day 1.
Fetuses and placentas were weighed. Placentas were halved,
one half was frozen on dry ice for nucleic acid or protein
extraction, while the other half was either fixed in Carnoys
fixative and later processed for paraffin histology, or embed-
ded directly in Tissue-Tek O.C.T. Compound (Sakura) and
used for cryo-sectioning. For determination of blood glucose
levels, newborn mice were decapitated and blood glucose
determined with a OneTouch UltraEasy glucose meter.
2.2 BrdU cell proliferation assay
Cellular proliferation in placental and fetal tissues was de-
termined using the BrdU assay according to Jägerbauer et al.
(1992).
2.3 Staining of sections
Antibodies used were against smooth muscle actin (DAKO
M0851) and BrdU (DAKO M0744), isolectin B4 was ob-
tained from Vector laboratories (B-1205). Horseradish
peroxidase-labelled secondary antibodies were obtained
from DAKO and Vector laboratories. IHC was carried out
according to standard procedures. Antigen retrieval was
performed in a microwave at 480 W for 10 min in 10 mM
citrate, 0.05% Tween20, pH 6.0. Frozen, 10% PFA post-
fixed sections were stained with Oil red O. Carnoys fixed
paraffin sections were stained with PAS. For counting of
nuclei, pictures were taken at 40× magnification and quanti-
fied on a screen. Three randomly selected areas from at least
3 different fetuses were analysed.
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2.4 DNA extraction and genotyping PCR
Genomic DNA was extracted from tissues using the
Promega Wizard genomic DNA extraction kit. The follow-
ing primers were used to genotype Cbx3 mutant mice: for-
ward: 5-AGTCCCAGTACTGAGAGTTC-3 and reverse:
5-CTCTACCTCCTGAGTACTAG-3. Reaction conditions
have been described previously (Brown et al. 2010).
2.5 Lipid extraction and analysis
For placental transport analysis (Wu et al. 2003; Yu et al. 2008),
total lipid was extracted and purified from Cbx3hypo/hypo and
Cbx3+/+ E13 and E18 fetuses and their placentas and the ratios
of EFAs (20:4; 18:2; 22:6) to NEFAs (16:0; 18:0) were deter-
mined. BSTFA containing 1% TMCS was from Thermo
(Runcorn, UK). All other chemicals were from Sigma Aldrich
(Schnelldorf, Germany). A Scion TQ GCMS system from
Bruker (Bremen, Germany) equipped with a Bruker BR5MS
15 m × 0.25 mm × 0.25 μm column was used. The injector was
operated in splitless mode, held at 280°C. The injection volume
was 1 μL and the oven program started and kept for 0.5 min at
90°C, ramped to 180 with 30°C/min, then to 250°C with 10°C/
min, then to 266°C with 2°C/min, and finally to 300°C with
120°C/min. Helium (99.9990%) was used as carrier gas at a
flow rate of 1.2mL/min. The retention times of all analytes were
determined, so the selected ion monitoring (SIM) method could
be programmed with a 0.30 min window for each compound.
For the analysis of the total lipid content, to ~1 mL
sample, 3 mL of methanol and 1 mL of 10 M NaOH were
pipetted into a pre-cleaned glass 10 mL test-tube. Before
closing the tube, the atmosphere in the vial was flushed with
argon. The tube was placed in an oven for 1 h at 90°C. After
cooling, 2 mL of 6 N of HCl were added, subsequently 10
μL internal standard (C16:0 d31) was added. Extraction was
carried out by adding 3 mL of n-hexane. After shaking, the
n-hexane layer was transferred to another tube. This was
done three times, to ensure an optimal extraction. n-Hexane
was added to the extract to 10 mL. 50 μL were taken from
the extract and dried in an autosampler vial.
Dried samples were derivatized by 25 μL of MtBSTFA
for 10 min at room temperature and subsequently 25 μL of
BSTFA and 2.5 μL of pyridine were added before putting
the sample in an oven for 15 min at 50°C. 947.5 μL of
n-hexane, containing 10 μg/mL octadecane (C18) inter-
nal standard, was used to dilute the sample, prior to
injection.
2.6 Quantitative real-time RT-PCR (qRT-PCR)
Gene expression levels were analysed by quantitative real
time PCR (Corbett Research RG-3000 thermo-cycler) for the
growth regulatory genes (Grb10, Igf2, H19), the placenta-
specific transcript of Igf2 (Igf2P0), the placental transporter
genes of the system A family of amino acid transporters
(Slc38a1, Slc38a2, Slc38a4), the predominant placental glu-
cose transporters (Slc2a1, Slc2a3), the prolactin family genes
(Prl, Prlr, Prl7b1, Prl3c1, Prl4a1, Prl8a9, Prl7c1), the key
enzymes in glucose homeostasis (G6pc, Pck1, Gys2), and
the genes related to lipid and mitochondrial metabolism
(Pparg2, Srebp1, Pgc1a, Ucp1, Cs, Hmgcs). Total RNA
was extracted from snap-frozen tissues with TRIzol reagent
(Ambion Life Technologies) according to manufacturers
guide. DNase treatment was performed prior to cDNA syn-
thesis with Promegas RQ1 RNase-Free Dnase Kit. cDNA
was synthesized using high-capacity cDNA Reverse
Transcription Kit of AppiledBiosystems. PowerSYBR®
Green PCR Master Mix (Life Technologies) was used for
real time PCR quantification of transcripts. All samples were
analysed in triplicates and data were normalized using Delta
Delta CT method (Livak and Schmittgen, 2001).
Accordingly, the amplification efficiency of the constitutive-
ly expressed reference genes, Tubb, Actb and 28s rRNA,
were compared of the amplification of the target genes of
interest (given above) in order to find the optimal combina-
tion of reference gene and target gene for calculation of
normalized expression as described by Livak and
Schmittgen (2001).
Conditions and primer sequences used in qRT-PCR are
shown in the table below.
Gene Forward Primer (5→ 3) Reverse Primer (5 → 3) Annealing Temp Product Size(bp)
Pparg2 GCATCAGGCTTCCACTATGGA AAGGCACTTCTGAAACCGACA 60 161
Prlr TGGTGGAATCCTGGGTCAGA CTTCCCATTTCGTTCGTGGC 58 194
Srebp1 CGGCTGTTGTCTACCATAAGCTG CATAGATCTCTGCCAGTGTTGCC 58 152
Pgc1a CCCAGGCAGTAGATCCTCTTCAA CCTTTCGTGCTCATAGGCTTCATA 58 162
Ucp1 TCTGCATGGGATCAAACCCC ACAGTAAATGGCAGGGGACG 58 215
Igf2 CGCTTCAGTTTGTCTGTTCG GCAGCACTCTTCCACGATG 58 95
Cs TGTTTCAGGGGCCTTTAAGACT CATGCTTCAGTCCCGGTCAT 63 181
Hmgcs1 CCTGGCACAGTACTCACCTC AGCCAAGCCAGAACCGTAAG 59 73
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3. Results
3.1 Effect of the Cbx3hypo allele on placental
and fetal growth
Placental and fetal weights were determined between E12
and E19 (figure 1). At E12 Cbx3hypo/hypo homozygous pla-
centas exhibited a tendency for reduced weight, compared to
both Cbx3hypo/+ and Cbx3+/+ placentas (figure 1c). From day
13 onwards weight differences between Cbx3hypo/hypo and
Cbx3+/+ placentas were statistically highly significant
(P<0.001; figure 1c), with the mean relative weight of the
Cbx3hypo/hypo placentas reaching a minimum at E14 and E16,
with 62.1% and 62.0% of wild-type weights respectively.
There was some catch-up on E18 and E19 where mean
relative weights of Cbx3hypo/hypo placentas reached 70.4%
and 74.8% of wild-type placentas respectively. Notably,
Cbx3hypo/+ placenta weights were consistently intermediate
between Cbx3hypo/hypo and Cbx3+/+ (figure 1c), indicating
that the Cbx3hypo allele is haplo-insufficient with regard to
placental weight. Specifically, the weight differences be-
tween Cbx3hypo/hypo and Cbx3hypo/+ placentas were signifi-
cant at all stages except E12 (P<0.05 for E13, P<0.001 for
all other stages); between Cbx3hypo/+ and wild-type pla-
centas, weight differences were significant on E13
(P<0.005), E18 (P<0.01), and E19 (P<0.01). With regard
to fetal weights, the weights of Cbx3hypo/hypo fetuses were
significantly reduced compared with both Cbx3hypo/+ and
Cbx3+/+ fetuses from day 16 onwards (figure 1d).
These data indicate that the reduced placental weights we
observed from day 13 (figure 1c) could cause or contribute
to the fetal growth restriction that follows. Cbx3hypo/hypo
fetuses showed no catch-up growth during late gestation
unlike Cbx3hypo/hypo placentas. Neither was there any signif-
icant weight difference between Cbx3hypo/+ and Cbx3+/+
fetuses at any stage (figure 1d), showing that the Cbx3
haplo-insufficiency was only in the placenta.
3.2 Effect of the Cbx3hypoallele on proliferation
in placental and fetal tissues
It is known that differential cell proliferation is sufficient to
explain growth phenotypes (Zechner et al. 2002). To deter-
mine if reduced fetal and placental weights were caused by
decreased cell proliferation, we performed anti-BrdU immu-
nohistochemistry (IHC) and calculated the percentage of
BrdU-positive nuclei.
With regard to fetuses there was clear evidence for decreased
proliferation in Cbx3hypo/hypo vs. Cbx3+/+tissues at E13, with
18.5±3.0% vs. 32.9±4.1% BrdU-positive nuclei in heart
(figure 2a and b; P=0.001), 38.9±3.7% vs. 47.2±4.9%
BrdU-positive nuclei in lung (P=0.001), and 27.7±2.9% vs.
31.2±1.6% in tongue (P<0.002). On E18 no significant differ-
ence could be observed between hearts of Cbx3hypo/hypo and
wild-type fetuses (22.5±0.76 vs. 23.0±0.99; P=0.57). Notably,
at E18 the brown adipose tissue (BAT) ofCbx3hypo/hypo fetuses
exhibited significantly increased BrdU-incorporation compared
to wild-type BAT (figure 2c and d; 16.7±5.3% vs. 6.8±4.7%;
P<0.001).
With regard to the placenta, decreased proliferation
was observed in the E13 Cbx3hypo/hypo labyrinth, which
G6pc CTGCTGTGTCTGGTAGGCAA CCTGGGTCTCCTTGCCATTT 59 91
Pck1 TTGAACTGACAGACTCGCCC GGCACTTGATGAACTCCCCA 63 105
Gpd1 CAGGTCCCTCTCTGCTCCTA CCAGTCGGGATCGATGACAG 62 102
Atg5 AGTGGAGGCAACAGAAACCC TCCTGTGTGTCTCAGCGAAG 58 115
Atg7 TGCCTATGATGATCTGTGTC CACCAACTGTTATCTTTGTCC 54 146
Gys2 CTCTCCTGAAAGGCAGCAAGG ACAGGGTGAGCCAGCAATC 60 85
Cbx3 TGAAGTGGAAGGACTCGGAC GTAATTCAAAACCCAAGATCCAGA 58 200
Prlpn GGACACCAGTTTAGCAGCCT GTCTTCGGTGAGCATTTCGC 59 197
Prl3c1 AAAGTCGTTCTGGAGGGAGC TTTTGCCATGCTTCAGAGCC 62 211
Prl4a1 GACCACCAGATGCCACACTT TGGATCCCAGCCTTTCACAC 62 164
Prl8a9 CAGCTGGAACCCTTCGTACA ATCTGCATGCTCAGTTCCCC 62 188
Prl7c1 GCTGCCACACATTTTCCCTC GTTTAGGGTCCTGATGGCGT 56 200
Igf2p0 CTTCAGGAACTACGAAGCGACT GTCGTCGTAGTCGTTCTCCTCT 58 101
Slc2a1 AGCATCTTCGAGAAGGCAGG ACAACAAACAGCGACACCAC 58 98
Slc38a4 AGGGCTGTGAGGTCAAATGG AAATTGGCTGTTCATGGCGTC 58 142
Slc38a1 CTTGGCTACACGAGTGGGTT TGTCGAGTTCTGCTCCACAC 58 108
Slc38a2 CATCCCGCTGTTCTTCCCAT CCGATTCCACGTGTCCGTAA 58 154
Grb10 GGACAAAGTGGGGCAGTCAA GGCTTTCCACGGACGAGTTA 58 140
Slc2a3 GAACACTTGCTGCCGAGAAC AGATGGGGTCACCTTCGTTG 58 100
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had 38.7±5.1% BrdU-positive nuclei as compared to
51.5±10.8% in wild-type labyrinth (P<0.001). The E13
spongiotrophoblast, the supporting structure of the developing
labyrinthine layer, showed no significant differences in cell
proliferation (8.7±4.3 wt vs. 11.5±3.3 Cbx3hypo/hypo; P=0.09).
3.3 Placental morphology and function
Prompted by the observation that placental growth restriction
presaged the onset of fetal growth restriction (figure 1) and
may thus cause the fetal growth restriction, we decided to
Figure 1. Homozygosity for Cbx3hypo/hypo causes placental and fetal growth restriction. (a) An E19 Cbx3hypo/hypo conceptus whose
placental and fetal weights were 84.1 and 752 mg respectively. (b) An E19 Cbx3hypo/+conceptus whose placental and fetal weights were 107
and 1095 mg respectively. We have shown the comparison of the Cbx3hypo/hypo conceptus in (a) with the E19 Cbx3hypo/+conceptus in (b) so
that the similarity in size of the placentas can be seen, which is where the haplo-insufficiency for Cbx3hypo is observed. By contrast there is
an obvious difference in size of the fetuses. (c) Diagram of the weight increase of Cbx3hypo/hypo, Cbx3+/− and Cbx3+/+ placentas between
E12 and E19 of gestation; values are shown as x±S.D. (d) Diagram of the weight increase of Cbx3hypo/hypo, Cbx3+/− and Cbx3+/+ fetuses
between E12 and E19 of gestation and for post partum day 1 (PP1) newborn mice; values are shown as x±S.D. Statistical
significance was assessed by unpaired t-test. Number of conceptuses: E12 - hypo/hypo=4; hypo/+=7; +/+=5; E13 - hypo/hypo=
16; hypo/+=53; +/+=25; E14 - hypo/hypo= 9; hypo/+=18; +/+=8; E16 - hypo/hypo=8; hypo/+=18; +/+=9; E18 - hypo/hypo= 10;
hypo/+=23; +/+=12; E19 - hypo/hypo=25; hypo/+=61; +/+=22; PP1 - hypo/hypo= 13; hypo/+=24; +/+=15; hypo/hypo=Cbx3hypo/hypo;
hypo/+=Cbx3+/hypo; +/+=Cbx3+/+; green bars=Cbx3hypo/hypo; red bars=Cbx3hypo/+; blue bars=Cbx3+/+.
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investigate placental morphology and function in more
detail. We compared the placental morphology of
Cbx3hypo/hypo and wild-type placentas between E12 and
E19 of gestation using hematoxylin and eosin (HE), an
anti-smooth muscle actin (SMA) antibody and isolectin-
B4 (BSB4) that marks the matrix surrounding fetal
blood vessels (Wood et al. 1979; Kurz et al. 1999).
We did not observe any consistent alterations of placental
morphology in early post-mid gestation Cbx3hypo/hypo
placentas, but we did observe some changes in late gestation
Cbx3hypo/hypo placentas. First, as shown in figure 3a to d, we
observed increased staining, both in terms of the numbers of
cells and staining intensity, of the SMA-positive pericytes.
Apart from this enhanced staining of pericytes smooth muscle
differentiation looked normal in late gestation Cbx3hypo/hypo
placentas. Second, there was decreased BSB4-staining (C.f.
figure 3e with 3f) that was associated with decreased width of
blood vessels. Third, we observed increased numbers of nuclei
per given area in sections of late gestation Cbx3hypo/hypo pla-
centas compared to wild-type placentas. E18 and E19
Cbx3hypo/hypo placental sections showed significantly
higher nuclear density in the labyrinth compared to
wild-type placentas (E18: 291±35.3 vs. 257±35.6; E19:
315±51 vs. 206±42; P<0.001; C.f. figure 3i with 3j).
This contrasted to the situation found at E12 where
nuclear density in the labyrinth was reduced in
Cbx3hypo/hypo compared to wild-type placentas (231±16
vs. 273±17; P=0.02; C.f. figure 3g with 3h); analysis of
intervening stages showed that the tendency for reduced
nuclear density in Cbx3hypo/hypo labyrinth persisted until
E14. These findings indicate that after E14 the Cbx3hypo/
hypo placentas compensate by increasing cell number and
thus the surface area for exchange of nutrient, gas and
waste exchange between the fetal and maternal blood
supplies.
We next measured changes in mRNA transcripts of genes
whose expression is known to change during the placental
growth restriction that results from undernourishment of
dams (Coan et al. 2010). They included placental growth
regulators, amino acid and glucose transporters (figure 3k).
In E19 Cbx3hypo/hypo placentas expression of the placenta-
specific transcript of Igf2, Igf2P0, and of Grb10 are reduced
Figure 2. Cellular proliferation in Cbx3hypo/hypo and Cbx3+/+ fetal tissues. Cellular proliferation was determined by BrdU-IHC. (a) BrdU-
IHC on a section of E13 Cbx3hypo/hypo heart. (b) BrdU-IHC on a section of E13 Cbx3+/+ heart that is a littermate of the fetus in (a).
Comparison of (a) with (b) shows that there is reduced BrdU incorporation in the Cbx3hypo/hypo heart. (c) BrdU-IHC on a section of E18
Cbx3hypo/hypo BAT. (d) BrdU-IHC on a section of E18 Cbx3+/+ BAT that is a littermate of the fetus in (c). Comparison of (c) with (d) shows
that there is increased BrdU incorporation in the Cbx3hypo/hypo BAT. Number of tissues counted: hypo/hypo=4; +/+=4; three areas were
analysed from each tissue. Magnifications are ×40 of the original.
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Figure 3. Altered placental morphology of Cbx3hypo/hypo placentas. Morphology of placentas was investigated using anti-smooth muscle
actin (SMA) and Isolectin BSB4 IHC. (a, c) Anti-SMA IHC on placental sections of E19 Cbx3hypo/hypo. (b, d) Anti-SMA IHC on placental
sections of E19 Cbx3+/+ that is a littermate of the animal in (a, c). Comparison of (a, c) with (b, d) shows that there both an increase in the
number and in the intensity of staining of the SMA-positive pericytes in Cbx3hypo/hypo placentas. (e) Isolectin BSB4-staining of E19
Cbx3hypo/hypo placenta. (f) Isolectin BSB4-staining of E19 Cbx3+/+ placenta. Comparison of (e) and (f) shows decreased width of blood
vessels in Cbx3hypo/hypo placentas. Number of placentas analysed: hypo/hypo=6; +/+=6. (g to j) The nuclei of E12 to E19 placental sections
from Cbx3hypo/hypo and Cbx3+/+ littermates were stained and counted. Comparing the number of nuclei in E12 Cbx3hypo/hypo (g) placentas to
that of Cbx3+/+ (h) littermates showed that the nuclear density was reduced in E12 Cbx3hypo/hypo placentas (number of placentas counted:
hypo/hypo=2; +/+=2; 3 areas were analysed from each placenta). By contrast, E19 Cbx3hypo/hypo placentas shown in (i) exhibited higher
nuclear density in the labyrinth than Cbx3+/+ littermates shown in (j) (number of placentas analysed: hypo/hypo=4; +/+=2; 3 areas were
analysed from each placenta). (k) Normalized real time PCR transcripts of genes relevant to placental growth and transport function. mRNA
transcripts in Cbx3hypo/hypo placentas were measured on E19 (black, filled bars) and compared to Cbx3+/+ transcript levels that were
normalized to 1.0 (empty bars). Significant expression changes are indicated by asterisks (*p< 0.05; **p<0.01). Statistical significance was
assessed by unpaired t-test. Cbx3hypo/hypo gene expression levels are indicated by filled bars, Cbx3+/+ levels, normalized to 1.0, by empty
bars (number of placentas analysed: hypo/hypo=3; +/+=3). Magnification in (a, b) is ×10 and (c to j) is ×40 of the original.
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to 78%and 70% of wild-type respectively. There was no
significant change in expression of the growth regulator
H19. E19 Cbx3hypo/hypo placentas showed significantly re-
duced expression of mRNA transcripts in two of the three
members of the system A amino acid transporter family,
Slc38a1 (down to 80% of wt) and Slc38a2 (down to 78%
of wt). There was no significant change in the expression of
the Slc38a4 gene.There was a dramatic reduction in the
mRNA transcript of placental glucose transporter gene,
Slc2a3, to 58% of wild-type levels. The Slc2a1 mRNA
transcript was also reduced to 83% of wild-type levels.
To directly test placental transport function we deter-
mined essential fatty acid (EFA) transport across the
placenta. We used the method detailed in Wu et al.
(2003) and Yu et al. (2008) and measured fetal and
placental ratios of EFAs: non-essential FAs (NEFAs) in
Cbx3hypo/hypo and wild-type littermates at E13 and E18.
At E13 there was no significant difference in placental
EFA:NEFA ratios in two litters that were investigated. In
one of the E13 litters there was a significantly reduced
EFA:NEFA ratio in the fetuses, with values of 1.67±0.21
in Cbx3hypo/hypo (N=2) vs. 2.44±0.21 in wild-type and
heterozygous (N=3; P<0.05). However, fetuses of the
second E13 litter showed no significant differences, with
EFA:NEFA ratios of 3.23±0.04 in Cbx3hypo/hypo (N=2) vs.
2.98±0.21 in control littermates (N=2). Examination of an
E18 litter, which comprised two Cbx3hypo/hypo fetuses and
four wild-type and heterozygous controls, showed that the
EFA:NEFA ratios were significantly reduced in the heads
of the Cbx3hypo/hypo fetuses (1.83±0.12 vs. 2.51±0.14;
P=0.02), but not in the rest of the bodies (2.15±0.21 vs.
2.65±0.69; P=0.16) or in the placentas.
3.4 Newborn Cbx3hypo/hypo mutants do not exhibit major
morphological abnormalities
We have previously shown that roughly 99% of
Cbx3hypo/hypo homozygotes on a mixed 129/Sv-C57BL/6
genetic background die before weaning, whereas during
prenatal development normal Mendelian ratios of Cbx3hypo
to wild-type alleles were observed (Brown et al. 2010). The
nature and the timing of the postnatal attrition of Cbx3hypo/hypo
homozygotes was not determined (Brown et al. 2010). A
number (N=10) of post-partum (PP1) day 1 litters from
Cbx3hypo/+ × Cbx3hypo/+matings were analysed. The pre-
natal fetal weight restriction (figure 1) persisted in post-
natal Cbx3hypo/hypo pups. At PP1 Cbx3hypo/hypo body
weights were 79% of Cbx3hypo/+ and Cbx3+/+ combined
(P<0.001; figure 1d). When a PP8 litter consisting of
four pups was analysed, body weights were 3,805 and
3,288 mg for Cbx3hypo/hypo and 5,657 mg and 5,756 mg
in a Cbx3+/+ and a Cbx3hypo/+, respectively; Cbx3hypo/hypo
weights were 62% of wild-type. Reduced body weight had
also been observed in the adult Cbx3hypo/hypo mice described
previously (Brown and Singh, unpublished).
Stomachs of PP1 Cbx3hypo/hypo pups frequently
contained no milk (C.f. figure 4a with 4d) and most
were found dead or dying at around noon of PP1at the
periphery of the group/huddle of littermates. Death also
occurred when competing wild-type and heterozygous
littermates had been removed. Only three Cbx3hypo/hypo
pups survived beyond PP1: one pup died on PP2, and
two pups from one litter were sacrificed on PP8 for
analysis. The mortality of the Cbx3hypo/hypo homozygotes
was too early to be explained by non-feeding alone
because non-feeding mice that do not suckle die within
a time window of 1224 h after birth (Turgeon and
Meloche 2009).
External examination of Cbx3hypo/hypo pups provided no
explanation for the severe neonatal mortality. Cbx3hypo/hypo
newborns possessed neither the characteristic Cbx1−/−
hunch-back phenotype (Aucott et al. 2008), nor any cyano-
sis. They also exhibited a normal righting reflex and were
not anosmic. Internal examination of Cbx3hypo/hypo,
Cbx3hypo/+ and control wild-type PP1 pups revealed no ob-
vious malformation of organ systems necessary for postnatal
survival, such as heart and kidneys. However, we consistent-
ly observed reduced vascularization of the intestines and the
intrascapular BAT in Cbx3hypo/hypo pups (not shown).
Vascularization of the intestines largely occurs postnatally
and is induced by milk uptake; notably, as shown in
figure 4a and d, milk was frequently absent from the
stomachs of PP1 Cbx3hypo/hypo pups. BAT is the main site
of thermogenesis in neonatal mice and vascularization of this
tissue is required because of the high oxygen demands of this
process (Crandall et al. 1997; Lim et al. 2012). The
changes in vascularization of the intestines and BAT
prompted us to examine defects in metabolism and en-
ergy homeostasis as the cause of the neonatal mortality
because such defects may result in neonatal mortality in
the absence of overt morphological abnormalities
(Turgeon and Meloche 2009).
3.5 Cbx3hypo/hypo neonates are hypoglycemic
and have reduced amounts of glycogen
Blood glucose measurements showed that PP1 Cbx3hypo/hypo
neonates had significantly lower blood glucose levels
than wild-type or heterozygous pups, with concentrations
of 2.1±0.6 mmol/L (N=9; range 3.1<1.1 ) as compared
to 3.1±0.5 mmol/L (N=17; range 3.82.1; P<0.006) re-
spectively. In two of the PP1 Cbx3hypo/hypo pups glucose
levels were below the detection limit of 1.1 mmol/L.
Moderately reduced blood glucose levels were also ob-
served in the two PP8 Cbx3hypo/hypo pups, even though
they were found to have full stomachs upon dissection,
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Figure 4. Cbx3hypo/hypo neonates exhibit symptoms of defective energy homeostasis. (a) A Cbx3hypo/hypo newborn approximately 4 h after
birth. Comparison of the Cbx3hypo/hypo newborn with its Cbx3+/+ littermate in (d) shows that the stomach of the Cbx3+/+ pup is filled with
milk, as marked by the white arrow. The Cbx3hypo/hypo newborns stomach is empty (see white arrow). (b to f) Liver glycogen was stained
with PAS in PP1 and E19 Cbx3hypo/hypo and Cbx3+/+ livers. Comparing the PAS-staining of the PP1 Cbx3hypo/hypo liver section in (b) with
its PP1 Cbx3+/+ littermate in (e) shows a dramatic reduction of glycogen in the PP1 Cbx3hypo/hypo liver. There was no difference in PAS-
staining between staining between E19 Cbx3hypo/hypo liver sections given in (c) with its E19 Cbx3+/+ littermate in (f). (g to j) BAT sections
from E19 and PP1 Cbx3hypo/hypo and Cbx3+/+ littermates were stained with lipid-specific stain Oil Red O (ORO). Comparison of ORO-
stained BAT sections showed either complete absence or strong reduction of lipid in BAT sections of Cbx3hypo/hypo both at E19 (i) and PP1
(g) as compared to E19 (j) and PP1 (h) Cbx3+/+ littermates. (k) Normalized real time PCR transcripts of genes expressed in Cbx3hypo/hypo
BAT, placenta and liver. mRNA transcripts were measured on E19 (black, filled bars) and PP1 (cross-hatched) and compared to Cbx3+/+
transcript levels that were normalized to 1.0 (empty bars). Significant expression changes are indicated by asterisks (*p<0.05; **p<0.01).
Statistical significance was assessed by unpaired t-test. Number of animals analysed: BAT for ORO - hypo/hypo=6; +/+=6; BAT for gene
expression - hypo/hypo=5; +/+=5 for E19 and hypo/hypo=3; +/+=4 for PP1; liver for PAS - hypo/hypo=6; +/+=6; liver for gene expression
hypo/hypo=3; +/+=3 for E19 and hypo/hypo=4; +/+=2 for PP1; placenta for gene expression hypo/hypo=3; +/+=3. PCRs were repeated 3
times.
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with 5.6 and 5.7 mmol/L (two Cbx3hypo/hypo pups) com-
pared to 6.8 (Cbx3+/+) and 7.5 mmol/L (Cbx3hypo/+) in
control littermates.
Staining of livers for PAS showed that there was reduced
glycogen in newborn (PP1) Cbx3hypo/hypo (figure 4b) (N= 6)
livers compared to wild-type (figure 4e) (N=6). There was
no difference in PAS staining of PP1 hearts (not shown)
indicating that the depletion of liver glycogen is likely to
be a secondary consequence to the inability of Cbx3hypo/hypo
newborns to suckle and take on carbohydrate in the milk
(figure 1a and d), which would be transported back to the
liver via the intestines. This would also be consistent with
the observation that depleted glycogen reserves were limited
to postnatal livers because fetal (E19) Cbx3hypo/hypo (N=6)
and wild-type (N=6) livers showed no difference in PAS
staining (C.f. figure 4c with 4f).
Given the hypoglycemia and reduction in glycogen deposits
in PP1 Cbx3hypo/hypo livers we investigated mRNA transcript
levels of three genes coding for enzymes active in glucose/
glycogen metabolism by qRT-PCR on days E19 and PP1. The
genes were glycogen synthase (Gys2), glucose-6-phosphatase
(G6pc) and phosphoenolpyruvate carboxykinase (Pck1). As
shown in figure 4k Pck1 was up-regulated in Cbx3hypo/hypo
mutants at both E19 and PP1 by 1.4- and 2.3-fold respectively.
G6pc transcript levels were also up-regulated 2.4-fold on PP1,
but showed a moderate 0.8-fold down-regulation on E19
(figure 4k). There were no significant changes in expression
of Gys2 (figure 4k).
3.6 Cbx3hypo/hypo homozygotes are deficient
in BAT lipid deposits
The finding that BAT vascularization is reduced inCbx3hypo/hypo
homozygotes indicated that the function of this tissue
might be impaired. We therefore decided to examine the
histology and lipid content by HE and Oil red O staining
of BAT from PP1 Cbx3hypo/hypo and wild-type pups. HE
revealed that BAT of Cbx3hypo/hypo mutants exhibited a
higher nuclear density that was likely due to reduced cell
volume (C.f. figure 4g with 4h). The difference in Oil Red O
staining of PP1 Cbx3hypo/hypo (N=9) BAT compared to wild-
type or Cbx3hypo/+ controls (N=9) was striking. Lipid was
either absent or strongly reduced in Cbx3hypo/hypo BAT (C.f.
figure 4g with 4h); this strong reduction in lipid content could
explain the decreased cell volume in Cbx3hypo/hypo BAT. We
next asked whether the reduction of lipid was also found
prenatally. Accordingly, we stained BAT of E19 Cbx3hypo/hypo
fetuses with Oil Red O and showed that the lipid was also
reduced in the BAT of E19 Cbx3
hypo/hypo
fetuses (9 mutant vs. 7
wild-type or heterozygous) (C.f. figure 4i with figure 4j). The
prenatal depletion of lipidCbx3hypo/hypoBAT indicates that the
depletion was not caused solely by the inability to suckle.
The abnormal development of BAT prompted us to in-
vestigate real time mRNA transcription of genes involved in
lipid metabolism and BAT differentiation in Cbx3hypo/hypo
BAT. We measured mRNA transcripts of three genes in-
volved in lipid metabolism, Pparg2 (Jones et al. 2005),
Srebf1 (Eberlé et al. 2004) and Hmgcs (Goldstein and
Brown 1990). For BAT differentiation we measured
mRNA transcripts for Prlr (Budge et al. 2002), Igf2,
Pgc1a (Wu et al . 1999), Citrate synthase (Cs)
(Kloosterboer et al. 1979) and Ucp1. We observed similar
levels of mRNA transcripts for Pparg2 and Hmgcs while
Sreb1 transcription was elevated in Cbx3hypo/hypo BAT
(figure 4k). Hmgcs is a target gene of SREBF1 protein
(Horton et al. 2003). The lack of any change in Hmgcs
expression indicates that Hmgcs may be regulated indepen-
dently of SREBF1 in BAT. Cs is a quantitative marker for
mitochondria (Kloosterboer et al. 1979) indicating that the
number of mitochondria is unlikely to be changed in
Cbx3hypo/hypo BAT. Prlr showed no change in expression
but there was up-regulation of Igf2 in Cbx3hypo/hypo BAT
onE19 but not on PP1 (figure 4k). Notably, mRNA transcripts
of BAT-specific thermogenic genes Pgc1a and Ucp1 were
significantly reduced on both E19 and PP1 (figure 4k), with
Ucp1 showing a marked 10-fold down-regulation on E19.
In addition to measuring specific transcripts in BAT we
also investigated whether there was any effect of the
Cbx3hypo/hypo mutation on placental prolactin (Prl) mRNA
levels. We were prompted to do this because the placenta
expresses Prl and prolactin is known to be involved in BAT
development (Budge et al. 2002), so it was possible that
changes in placental Prl expression could cause the changes
in BAT. We also extended our investigation to measuring
transcript levels of several members of the prolactin gene
family (Wiemers et al. 2003), including Prl3c1, Prl4a1,
Prl7b1, Prl7c1 and Prl8a9. qRT-PCR showed that mRNA
transcripts from the Prl gene were expressed at similar levels
in E19 Cbx3hypo/hypo and wild-type placentas (figure 4k).
Expression of mRNAs from all other family members was
significantly up-regulated in E19 Cbx3hypo/hypo placentas
(figure 4k). The up-regulation ranged from around a 2-fold
increase for Prl4a1, Prl7c1 and Prl8a9 to 3-fold for Prl7b1
and 6-fold for Prl3c1.
4. Discussion
Mammalian Cbx genes have non-redundant functions
(reviewed in Singh 2010). This was first shown for the
Cbx1 gene where the proximate cause of the neonatal lethal-
ity of Cbx1−/− mice was the inability of the lungs to inflate
because of defective innervations of the diaphragm (Aucott
et al. 2008). Ablation of the Cbx5 gene results in a specific
silencing defect within the T-cell lineage (Allan et al. 2012)
although Cbx5−/− mice are viable and fertile (cited in Aucott
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et al. 2008). Here we show that the severe neonatal attrition
seen in Cbx3hypo/hypo mutants likely results from an accumu-
lation of deleterious lesions that begin during development
in utero.
4.1 Cbx3hypo/hypo mutants are at a disadvantage
at birth compared to wild-type
Depletion of CBX3 protein impedes fetal and placental
growth. Placental growth restriction in Cbx3hypo/hypo concep-
tuses starts before the observed fetal growth restriction;
Cbx3hypo/+ placentas are intermediate in size between
Cbx3hypo/hypo and wild-type placentas indicating a haplo-
insufficiency and that placental growth is exquisitely sensi-
tive to depletion of CBX3 protein. The first sign that
Cbx3hypo/hypo placental weights were statistically smaller
than wild-type was on E13 and correlates with both reduced
cell proliferation and nuclear density within the labyrinth of
the placenta, which is the site of nutrient, gas and waste
exchange between the fetal and maternal blood supplies
(Watson and Cross 2005). The weight disparity between
Cbx3hypo/hypo and wild-type was greatest between E14 and
E16, thereafter the placenta appears to compensate for its
small size; the disparity was narrowed but was never closed.
One compensatory mechanism that began at around E14 was
an increase in nuclear density within the labyrinth of
Cbx3hypo/hypo placentas. The increase in nuclear density
was still manifested in E19 Cbx3hypo/hypo placentas and
might provide a compensatory mechanism to increase inter-
face between the fetal and maternal blood supplies.
The catch-up in Cbx3hypo/hypo placental weight was not
reflected in the trajectory of Cbx3hypo/hypo fetal weights
during development: there is no catch-up in the weight of
Cbx3hypo/hypo fetuses during development. We did not find
an increase in cell proliferation in Cbx3hypo/hypo heart, lung
or tongue. There was one exception in that Cbx3hypo/hypo
BAT exhibited increased cell proliferation compared to wild-
type. Although unlikely to contribute significantly to overall
fetal weight because of its small size the increased cell
proliferation in Cbx3hypo/hypo BAT may represent a compen-
satory mechanism in an organ that is important for early
postnatal life: BAT is responsible for the rapid production
of heat at birth (Cannon and Nedergaard 2004).
Nutrient supply from the placenta to the fetus is not only
dependent on the size of the placenta but also on its mor-
phology, blood flow and the abundance of the various trans-
port mechanisms. All three of these characteristics appear to
be compromised in the Cbx3hypo/hypo mutant placentas. We
observed a morphological narrowing of the placental blood
vessels in late gestation Cbx3hypo/hypo placentas that is likely
due to a reduction of the intracellular matrix surrounding the
vessels; the smooth muscle appeared normal. Narrowing of
placental blood vessels would reduce blood flow and thus
nutrient exchange and exacerbate any problems in transport
across the placenta. Our investigation of transport mecha-
nisms was revealing. In E19 placentas there was down-
regulation of genes that promote placental growth such as
the placenta-specific transcript of Igf2, Igf2P0, and Grb10.
The reduced expression of Igf2P0 is of interest because it is
known to be important for placental growth (Constancia
et al. 2002) and placental transport through regulation of
genes such as Slc38a2 that encode transporter proteins
(Sferruzzi-Perri et al. 2011). Notably, the mRNA transcripts
of both glucose (Slc2a1 and Slc2a3) and amino-acid
(Slc38a1 and Slc38a2) transporters were significantly re-
duced showing that placental transport function is likely
to be compromised in Cbx3hypo/hypo placentas. We directly
tested transport capacity by measuring the cumulative trans-
port of EFAs across Cbx3hypo/hypo and wild-type placentas.
EFA transport is strictly regulated and involves several protein
classes, such as FA translocases and FA transport proteins
(Duttaroy 2009). Our results indicated that there was likely to
be a defect in placental transport in Cbx3hypo/hypo placentas.
Specifically, we found that Cbx3hypo/hypo fetuses in one of two
E13 litters showed a significant reduction in the EFA:NEFA
ratio and the Cbx3hypo/hypo heads of an E18 litter showed a
reduced EFA:NEFA ratio.
The picture that emerges is that Cbx3hypo/hypo placentas
are affected first, with abnormalities observed in placental
morphology, blood supply and transport. These defects are
likely to contribute to the fetal growth restriction that fol-
lows. An important player is, we suggest, the placenta-
specific Igf2P0 transcript. Down-regulation of the Igf2P0
transcript could set in motion the growth and transport de-
fects we observe in the Cbx3hypo/hypo placentas. A key ex-
periment will be to test whether CBX3 protein binds the
Igf2P0 gene, which would support a role for CBX3 in
facilitating proper elongation of Igf2P0 transcript.
4.2 Loss of energy homeostasis in Cbx3hypo/hypo neonates
The small Cbx3hypo/hypo neonates show no overt morpholog-
ical abnormalities. Reduced size cannot alone explain the
severe postnatal mortality. For example, ablation of the
Igf2P0 transcript is not associated with postnatal mortality
despite Igf2P0 null newborns being even smaller than
Cbx3hypo/hypo newborns  69% (Igf2P0 null mutant)
(Constancia et al. 2002) vs. 78% (Cbx3hypo/hypo mutant).
Other defects in Cbx3hypo/hypo mutants must be involved in
the postnatal mortality. From our results there are good
candidates that could contribute to the postnatal mortality
of Cbx3hypo/hypo newborns.
One of the observations was that there was a likely disrup-
tion of glucose/glycogenmetabolism inCbx3hypo/hypomutants.
Any hypoglycemia would have been compounded by the lack
of suckling of PP1 Cbx3hypo/hypo pups that would in turn lead
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to depletion of liver glycogen reserves. The compensatory up-
regulation of G6pc on PP1was ineffectual because there were
little glycogen reserves upon which the enzyme could act. The
up-regulation of liver Pck1, whose product is the rate limiting
step of gluconeogenesis from non-carbohydrate sources
(Chakravarty et al. 2005), on E19 and PP1 was also insuffi-
cient to alleviate the hypoglycemia. We also observed a dra-
matic depletion of lipid stores in BAT and the reduced
expression of two BAT-specific thermogenic genes, Pgc1a
and Ucp1. Pgc1a is involved in activation of the Ucp1gene
in BAT (Puigserver et al. 1998) and, importantly, the UCP1
protein is responsible for non-shivering thermogenesis in BAT
(Matthias et al. 2000). We did not observe any changes in
expression of the prolactin (Prl) gene in the placenta or of the
gene encoding its cognate receptor (Prlr) in BAT, both of
which are involved BAT differentiation (Budge et al. 2002;
Viengchareun et al. 2008). We did observe changes in placen-
tal expression in other members of the prolactin gene family
but it is unclear what this means for BAT differentiation.
Given the broad euchromatic distribution of CBX3
(Horsley et al. 1996) and its role in transcriptional elongation
of mRNA transcripts (Vakoc et al. 2005; Hediger and Gasser
2006), depletion of CBX3 is likely to have widespread
effects on decreasing transcriptional elongation of many
genes. Accordingly, CBX3 depletion may explain the
down-regulation of mRNAs for growth regulators, Igf2P0
and Grb10, glucose (Slc2a1 and Slc2a3) and amino-acid
(Slc38a1 and Slc38a2) transporters in the placenta. The
dramatic reduction of the Ucp1 mRNA transcripts in BAT
is of particular significance, especially in the context of the
depleted lipid stores. This is because UCP1 protein is re-
sponsible for non-shivering thermogenesis in BAT (Matthias
et al. 2000). UCP1 increases the conductance of the inner
mitochondrial membrane so that BAT mitochondria generate
heat instead of ATP (Nicholls and Locke 1984). There is also
an essential requirement of long chain fatty acids (LCFA) in
this process. UCP1 is a LCFA anion/H+ symporter and has
an absolute requirement for LCFA in order to function
(Fedorenko et al. 2012). Thus the dramatic decrease in
transcription of Ucp1 and the almost complete loss of lipid
stores would render the heat-generating capacity of
Cbx3hypo/hypo BAT practically negligible.
The mechanism by which CBX3 protein activates Ucp1
expression may be as a constituent of the PRDM16 tran-
scriptional complex (Seale et al. 2008), which contains the
histone H3K9 methyltransferase EHMT1 (Ohno et al. 2013).
Depletion of CBX3 could destabilize the PRDM16 transcrip-
tional complex in a manner that has already been described
after loss of EHMT1 protein (Ohno et al. 2013). Loss of
PRDM16 or EHMT1 activity decreases Upc1 expression to
50% and 33% of wild-type levels respectively (Seale et al.
2008; Ohno et al. 2013). By contrast Upc1 expression is
reduced 10-fold in E19 Cbx3hypo/hypo BAT indicating that
defects in other regulatory mechanism(s) reduce Ucp1 ex-
pression. We suggest that inhibition of transcriptional elon-
gation of Ucp1 and its activator, Pgc1a, might also
contribute to the decrease of Ucp1 mRNA transcripts in
Cbx3hypo/hypo BAT.
4.3 A scenario for the severe attrition of
Cbx3hypo/hypo neonates
The severe postnatal mortality of Cbx3hypo/hypo homozygotes
is similar to that observed in newborn rats that have been
subjected to experimental fetal growth restriction (FGR)
(Cogneville et al. 1975). Cogneville and colleagues generat-
ed unilateral FGR by clamping the uterine artery of one
uterine horn. Just as we observed for Cbx3hypo/hypo mutants,
the growth-restricted fetuses and newborn rats exhibited both
reduced lipid stores in BAT and a severe postnatal mortality
(Cogneville et al. 1975). It was argued that since BAT is
essential for non-shivering thermogenesis in altricial new-
born rodents, the postnatal depletion of lipids in BAT would
lead to rapid hypothermia, inability to suckle, hypoglycemia,
followed by death. However, work on mice deleted for Prlr
(prolactin receptor gene), which causes reduced formation of
BAT (Viengchareun et al. 2008), indicates that there is little
requirement for BAT in postnatal survival in the mouse
(Nadine Binart, personal communication), although, as ex-
pected, Prlr−/− pups do succumb more rapidly to cold expo-
sure than wild-type mice (Viengchareun et al. 2008).
Notwithstanding the observations with Prlr−/− mice, we
are persuaded that the scenario for neonatal death described
by Cogneville et al. (1975) is similar to that which brings
about the death of Cbx3hypo/hypo homozygotes. This is be-
cause Prlr−/− newborns are of normal size (Viengchareun
et al. 2008), unlike the Cbx3hypo/hypo pups and FGR neonates
(Cogneville et al. 1975). The smaller Cbx3hypo/hypo new-
borns would lose heat more rapidly compared to Prlr−/−
newborns because of the formers greater surface-to-volume
ratio (the square-cube law; Haldane 1926). Moreover, heat
loss may be further compounded because, in addition to
thermoregulation via BAT, thermoregulation in newborn
altricial rodents has a behavioural component termed hud-
dling (Alberts 1978; Sokoloff and Blumberg 2001; Harshaw
and Alberts 2012). Huddling close to littermates is protective
against the rapid heat loss that occurs during the brief expo-
sure to cool ambient temperatures that isolated pups experi-
ence when the dam leaves the nest (Harshaw and Alberts
2012). Notably, in a huddle of newborns there is competition
between pups and pups with functional BAT thermogenesis
tend to avoid contact with pups whose BAT thermogenesis
is blocked (Sokoloff and Blumberg 2001). Given that BAT
development is abnormal in the smaller-than-normal
Cbx3hypo/hypo newborns, heat loss is likely to be further
exacerbated by the mutants being pushed to the periphery
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of the nest where they do not experience the thermoregula-
tory benefit of huddling.
A scenario for the postnatal mortality is that Cbx3hypo/hypo
mutants are born small and hypoglycemic, largely due to abnor-
malities in placental morphology, blood supply and transport.
After birth, hypothermia sets in due to defective BAT-dependent
non-shivering thermogenesis and the lack of huddling. The hy-
poglycemia is further compounded by an inability to suckle and
depletion of glycogen reserves. These defects reinforce each other
and are severally necessary and jointly sufficient in bringing
about the demise of the majority of Cbx3hypo/hypo newborns.
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